🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

681 notícias encontradas para "presente"
Speaking another language could slow aging in the brain
Speaking another language could slow aging in the brain
People who speak more than one language seem to have younger brains, according to research presented at the Federation of European Neuroscience Societies (FENS) Forum 2026. Our brains are made up of billions of nerve cells that need to communicate with one another. As we age, con
Uterine aging linked to poorer pregnancy outcomes after 49 despite donor eggs
A major new study suggests that age-related changes in the uterus may contribute to poorer pregnancy outcomes, with women aged 49 and older experiencing lower live birth rates and higher miscarriage risk despite donor-oocyte treatment. Presented at the 42nd Annual Meeting of the
Blood test may help identify which colorectal cancer patients most likely to benefit from
Blood test may help identify which colorectal cancer patients most likely to benefit from
A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.
Just one exposure to cocaine alters mouse brain cells for 2 weeks, research reveals
Researchers studying the impact of cocaine in mice have found that just one exposure to the drug can create changes in brain cells that persist for at least two weeks. Their findings were presented at the Federation of European Neuroscience Societies (FENS) Forum 2026.
More than 1.15 million fertility treatment cycles in Europe in 2023 as impact of frozen em
More than 1.15 million fertility treatment cycles in Europe in 2023 as impact of frozen em
More than 1.15 million assisted reproductive technology (ART) treatment cycles were reported across Europe in 2023, according to preliminary data presented by the European IVF Monitoring (EIM) Consortium at the 42nd Annual Meeting of the European Society of Human Reproduction and
Foto: Aleksandr Slavich / Pexels
Air pollution may alter how sperm genes function, major fertility study finds
New research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) suggests that exposure to air pollution may affect genes associated with sperm development, raising new questions about male fertility, pregnancy outcomes and of
O overtraining é real mesmo? Existe a possibilidade de o corpo ser exigido demais?
O overtraining é real mesmo? Existe a possibilidade de o corpo ser exigido demais?
Treinar demais faz mal! Entenda o overtraining, seus sintomas e como o acompanhamento profissional é vital para sua saúde.
Modern IVF achieves higher success rates with single embryo transfer, major study finds
Modern IVF treatment can now achieve substantially higher success rates than historical approaches while dramatically reducing twin and triplet pregnancies, according to new research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology
Miscarriage and ectopic pregnancy admissions rise in recent years as stark inequalities pe
Hospital admissions for miscarriage and ectopic pregnancy have increased in England in recent years, according to research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE). The study abstract was published in Human Reproduc
Why does Parkinson's disease affect more men than women?
Why does Parkinson's disease affect more men than women?
New research presented at the Federation of European Neuroscience Societies (FENS) Forum 2026 has discovered some of the genetic changes in brain cells that may help explain why more men than women develop Parkinson's disease.
New clinical data advances stem cell-based cell therapy for Parkinson's disease
New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf dopaminergic progenitor cell product derived from human pluripotent stem cells for the
Long-term stroke data reveal stem cell therapy's safety, biological activity over years
Previously unpublished long-term clinical and imaging findings from participants treated with an induced pluripotent stem cell (iPSC)-derived neural progenitor cell therapy for chronic ischemic stroke were presented at the ISSCR 2026 Annual Meeting.